Investigating how e-cigarette warnings affect vaping behavior
Informing ENDS policies: Studying the impact of e-cigarette warnings on behavior
This study is looking at how different warning messages about e-cigarettes can help people decide whether to start or stop vaping, especially among young adults and older users, so we can create better health messages for everyone.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11077792 on NIH RePORTER |
What this research studies
This research examines the effectiveness of current and new e-cigarette warnings on user behavior, particularly focusing on how these warnings may influence vaping initiation and cessation among different age groups. The study will involve developing new warning messages based on data from large surveys and testing their impact through a randomized controlled trial (RCT) with young adult and adult e-cigarette users. By understanding which warnings resonate most effectively, the research aims to inform better public health messaging and policies regarding e-cigarette use.
Who could benefit from this research
Good fit: Ideal candidates for this research include young adults and adults who currently use e-cigarettes, particularly those who may also smoke combustible cigarettes.
Not a fit: Patients who do not use e-cigarettes or are not interested in quitting smoking may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective e-cigarette warnings that help reduce vaping among users and encourage quitting smoking altogether.
How similar studies have performed: Previous research has shown that effective health warnings can influence smoking behavior, suggesting potential success for this approach in the context of e-cigarettes.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Brewer, Noel Todd — Univ of North Carolina Chapel Hill
- Study coordinator: Brewer, Noel Todd
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.